Literature DB >> 20095156

Biologic characterization of H4, H6, and H9 type low pathogenicity avian influenza viruses from wild birds in chickens and turkeys.

Antonio C Morales1, Deborah A Hilt, Susan M Williams, Mary J Pantin-Jackwood, David L Suarez, Erica Spackman, David E Stallknecht, Mark W Jackwood.   

Abstract

The pathogenesis, virus shedding, and serologic response in specific-pathogen-free (SPF) chickens and commercial turkeys against H4, H6, and H9 type low pathogenic avian influenza viruses (LPAI) from wild birds was examined. Four-week-old chickens and three-week-old turkeys were given 1 x 10(6) EID50 of LPAI per bird, intrachoanally, and examined for clinical signs for 3 wk. Oropharyngeal and cloacal swabs, and fecal samples, were collected at 2, 4, and 7 days postinoculation (PI) for virus detection by real-time RT-PCR. Serum was collected at 7, 14, and 21 days PI and examined for antibodies against avian influenza virus (AIV) by the enzyme-linked immunosorbant assay (ELISA) and hemagglutination inhibition tests. Tissue samples for histopathology were collected from three birds per group at 3 days PI. The hemagglutinin genes of the viruses were sequenced, and phylogenetic analysis was conducted. Clinical signs ranged from no clinical signs to moderate depression, decreased activity, and decreased food and water consumption. Based on virus detection results, SPF chickens were generally found to be shedding more virus from both the oropharynx and cloaca than were commercial turkeys. Microscopic lesion results in both species showed the predominance of lesions in the respiratory and gastrointestinal tract, which is consistent with the fact that these viruses are of low pathogenicity. In chickens and turkeys, oropharyngeal shedding strongly correlated with the lesions found in the upper respiratory tract. Turkeys had fewer lesions in the respiratory tract and more lesions in the gastrointestinal tract compared to chickens. Thirteen LPAI viruses caused seroconversion in commercial turkeys, whereas only 6 LPAI viruses caused seroconversion in SPF chickens. Phylogenetic analysis of the HA genes showed that the H4, H6, and H9 viruses evaluated here represented the full genetic diversity of North American AIVs of their respective subtypes. This data is important for surveillance and control because some of the LPAI viruses (of wild bird origin and examined in this study) that can infect and be shed by chickens and turkeys would be difficult to detect in commercial poultry. Specifically, detection is difficult because these viruses did not cause overt clinical disease or mortality, but only induced mild microscopic lesions and exhibited poor seroconversion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20095156     DOI: 10.1637/8877-041509-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  16 in total

1.  Impact of route of exposure and challenge dose on the pathogenesis of H7N9 low pathogenicity avian influenza virus in chickens.

Authors:  Erica Spackman; Mary Pantin-Jackwood; David E Swayne; David L Suarez; Darrell R Kapczynski
Journal:  Virology       Date:  2015-02-06       Impact factor: 3.616

Review 2.  H9 Influenza Viruses: An Emerging Challenge.

Authors:  Silvia Carnaccini; Daniel R Perez
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 6.915

3.  Influenza A viruses grow in human pancreatic cells and cause pancreatitis and diabetes in an animal model.

Authors:  Ilaria Capua; Alessia Mercalli; Matteo S Pizzuto; Aurora Romero-Tejeda; Samantha Kasloff; Cristian De Battisti; Francesco Bonfante; Livia V Patrono; Elisa Vicenzi; Valentina Zappulli; Vito Lampasona; Annalisa Stefani; Claudio Doglioni; Calogero Terregino; Giovanni Cattoli; Lorenzo Piemonti
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

4.  The pathogenesis of low pathogenicity H7 avian influenza viruses in chickens, ducks and turkeys.

Authors:  Erica Spackman; Jack Gelb; Lauren A Preskenis; Brian S Ladman; Conrad R Pope; Mary J Pantin-Jackwood; Enid T McKinley
Journal:  Virol J       Date:  2010-11-19       Impact factor: 4.099

5.  The pathogenesis of H7N8 low and highly pathogenic avian influenza viruses from the United States 2016 outbreak in chickens, turkeys and mallards.

Authors:  Mary J Pantin-Jackwood; Christopher B Stephens; Kateri Bertran; David E Swayne; Erica Spackman
Journal:  PLoS One       Date:  2017-05-08       Impact factor: 3.240

6.  Persistence of low-pathogenic avian influenza H5N7 and H7N1 subtypes in house flies (Diptera: Muscidae).

Authors:  Anne Ahlmann Nielsen; Henrik Skovgård; Anders Stockmarr; Kurt Jensen Handberg; Poul H Jørgensen
Journal:  J Med Entomol       Date:  2011-05       Impact factor: 2.278

7.  Serological Survey for Avian Influenza in Turkeys in Three States of Southwest Nigeria.

Authors:  Daniel Oladimeji Oluwayelu; Comfort Oluladun Aiki-Raji; Oladunni Taiwo Adigun; Opeyemi Kazeem Olofintuyi; Adebowale Idris Adebiyi
Journal:  Influenza Res Treat       Date:  2015-11-17

Review 8.  Using quantitative disease dynamics as a tool for guiding response to avian influenza in poultry in the United States of America.

Authors:  K M Pepin; E Spackman; J D Brown; K L Pabilonia; L P Garber; J T Weaver; D A Kennedy; K A Patyk; K P Huyvaert; R S Miller; A B Franklin; K Pedersen; T L Bogich; P Rohani; S A Shriner; C T Webb; S Riley
Journal:  Prev Vet Med       Date:  2013-12-01       Impact factor: 2.670

9.  Development of dual-function ELISA for effective antigen and antibody detection against H7 avian influenza virus.

Authors:  Fang He; Mookkan Prabakaran; Yunrui Tan; Kartigayen Indira; Subaschandrabose Rajesh Kumar; Jimmy Kwang
Journal:  BMC Microbiol       Date:  2013-10-02       Impact factor: 3.605

10.  Surveillance of low pathogenic novel H7N9 avian influenza in commercial poultry barns: detection of outbreaks and estimation of virus introduction time.

Authors:  Amy Pinsent; Isobel M Blake; Michael T White; Steven Riley
Journal:  BMC Infect Dis       Date:  2014-08-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.